Secondary cvd prevention-Lipid modification strategies: A critical analysis.

Samit Ghosal, Binayak Sinha

Journal: Diabetes & metabolic syndrome 2018;11 Suppl 1():S187-S193

PMID: 28041920

Abstract

Lipid modification holds the key to effective secondary prevention of cardiovascular disease (CVD). However there is a controversy on whether it's all about targeting specific lipid sub fractions to a particular level or a direct effect of the agent(s) used or both. This review intends to look into these important issues from an evidence-based perspective. What is the appropriate timing of testing for lipid profile after a cardiovascular event? What is the rationale behind initiating with a high dose statin after an acute coronary event? What is the role of targeting lipid sub fractions beside LDL cholesterol? Is there any role for non-statin based therapy after an acute cardiovascular event? What constitutes a long-term lipid modification strategy in patients post CVD? These are very important questions, which needs to be addressed adequately as well as scientifically. The secondary CVD preventive strategies form a lipid perspective, which requires a thorough review.

Copyright © 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Address: Nightingale Hospital, 11 Shakespeare Sarani, Kolkata, India. Electronic address: [email protected].; AMRI Hospitals, JC-16/17, Salt Lake City, Kolkata 700091, India.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.